Narrow search
Showing 1 - 10 of 1,379
Cover Image
The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry
Banerjee, Tannista; Siebert, Ralph - 2014
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10010229875
Cover Image
Private versus social incentives for pharmaceutical innovation
González, Paula; Macho-Stadler, Inés; … - 2015
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a...
Persistent link: https://www.econbiz.de/10011406575
Cover Image
Dynamic effects of licensing and knowledge transfer across research stages : evidence from the pharmaceutical industry
Tian, Zhili; Siebert, Ralph - 2020
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and …
Persistent link: https://www.econbiz.de/10012219514
Cover Image
The effect of intellectual property rights on domestic innovation in the pharmaceutical sector
Gamba, Simona - 2016
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …
Persistent link: https://www.econbiz.de/10011509446
Cover Image
Pharmaceutical innovation, longevity, and medical expenditure in Greece, 1995 - 2010
Lichtenberg, Frank - 2015
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) - about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …
Persistent link: https://www.econbiz.de/10010473542
Cover Image
Dynamic mergers effects on R&D investments and drug development across research phases in the pharmaceutical industry
Siebert, Ralph; Tian, Zhili - 2020
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms' internal drug development capability. We evaluate the effects of M&As on firms' post-merger R&D...
Persistent link: https://www.econbiz.de/10012219372
Cover Image
Are ex ante and ex post licensing agreements useful instruments to lessen uncertainty in R&D?
Siebert, Ralph - 2013
In the last decades, technologies became more complex which increased the degree of uncertainty in R&D. To overcome the uncertainty, firms frequently engage in R&D collaborations, e.g., Research Joint Ventures (RJVs), and licensing agreements. While RJVs are well explored in the literature, very...
Persistent link: https://www.econbiz.de/10010223406
Cover Image
A dynamic analysis of licensing : the Boomerang effect and grant-back clauses
Choi, Jay Pil - 1999
licensing on R&D competition in the innovation market and to examine the rationale for often observed grant-back clauses. Of … in innovation markets. …
Persistent link: https://www.econbiz.de/10009781683
Cover Image
Market contestability and bribe solicitations : evidence across stages of firms' operations
Goel, Rajeev K.; Mazhar, Ummad; Saunoris, James W. - 2018
Adding to the literature on factors driving corruption and bribery, this paper examines the effect of contestability in business operations on bribe solicitations. Contestability undermines bureaucratic rent-seeking potential and this paper tries to capture this empirically using cross-country...
Persistent link: https://www.econbiz.de/10011822610
Cover Image
Vertical licensing, input pricing, and entry
Bakaouka, Elpiniki; Milliou, Chrysovalantou - 2017
We explore the incentives of a vertically integrated incumbent firm to license the production technology of its core input to an external firm, transforming the licensee into its input supplier. We find that the incumbent opts for licensing even when licensing also transforms the licensee into...
Persistent link: https://www.econbiz.de/10011597751